APA (7th ed.) Citation

Ruane, P., Strasser, S. I., Gane, E. J., Hyland, R. H., Shao, J., Dvory‐Sobol, H., . . . Shafran, S. (2019). Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study. Journal of Viral Hepatitis, 26(6), 770. https://doi.org/10.1111/jvh.13067

Chicago Style (17th ed.) Citation

Ruane, Peter, et al. "Sofosbuvir/Velpatasvir/Voxilaprevir for Patients with HCV Who Previously Received a Sofosbuvir/Velpatasvir‐containing Regimen: Results from a Retreatment Study." Journal of Viral Hepatitis 26, no. 6 (2019): 770. https://doi.org/10.1111/jvh.13067.

MLA (9th ed.) Citation

Ruane, Peter, et al. "Sofosbuvir/Velpatasvir/Voxilaprevir for Patients with HCV Who Previously Received a Sofosbuvir/Velpatasvir‐containing Regimen: Results from a Retreatment Study." Journal of Viral Hepatitis, vol. 26, no. 6, 2019, p. 770, https://doi.org/10.1111/jvh.13067.